ArticleAesthetic plastic surgery2026
Psychosocial and Socioeconomic Determinants of Stigma in Facial Localized Scleroderma.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundFacial localized scleroderma (LoS) often results in visible disfigurement and stigma, yet factors contributing to stigma in this population remain insufficiently characterized.
objectiveTo identify clinical, psychosocial, and socioeconomic factors associated with stigma in patients with facial LoS.
methodA cross-sectional study was conducted between June 2023 and June 2025 at a tertiary dermatology and plastic surgery center in China. Patients aged ≥ 12 years with stable facial LoS completed validated questionnaires assessing appearance satisfaction (FACE-Q), social support (SSRS), and stigma (Stigma Scale for Chronic Illness). Clinical and socioeconomic data were collected, and multivariate regression was used to identify independent predictors of stigma.
resultsOf 159 eligible patients, 123 completed the survey (mean age, 24.3 years; 66.7% female). Overall appearance satisfaction was low (FACE-Q mean, 47.8 ± 19.89). Higher stigma scores were independently associated with labial involvement, lower FACE-Q scores, and reduced social support. Lack of health insurance predicted greater intrinsic stigma, whereas residence outside first-tier cities was associated with higher extrinsic stigma. Disease severity (LoSDI) was not associated with stigma. Most patients reported limited awareness of reconstructive options, with dermatologists serving as the primary source of information.
conclusionsStigma in facial LoS is driven primarily by appearance dissatisfaction, inadequate social support, and socioeconomic disparities rather than clinical disease severity. These findings highlight stigma as a critical component of disease burden and support the need for multidisciplinary, patient-centered care integrating psychosocial support and improved access to reconstructive interventions. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Indexed as
Identifiers
42593490What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.